Trial Profile
Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Hip Labral Repair or Reconstruction Surgery
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2015
Price :
$35
*
At a glance
- Drugs RNS 60 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Revalesio
- 05 Feb 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov
- 08 Jan 2014 Planned initiation date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 14 Dec 2013 New trial record